Morning Brief
Markets ease, Oracle shakeup, Trump’s $100K visa fee
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
US stocks pull back from record highs as investors await Fed commentary and key inflation data later this week. Gold hits fresh records while bitcoin retreats. Oracle (ORCL) announces a leadership transition, with CEO Safra Catz moving to executive vice chair and Clay Magouyrk and Mike Sicilia named co-CEOs. The shuffle comes after Oracle’s blowout cloud forecast and major AI deals. Big Tech also faces disruption from President Trump’s new executive order imposing a one-time $100,000 fee on all new H-1B visas, sparking concern in Silicon Valley and sending Indian IT stocks lower. Pfizer (PFE) agrees to acquire obesity drug startup Metsera for $4.9B upfront plus milestones. At the same time, Johnson & Johnson spin-off Kenvue (KVUE) slumps on reports that the Trump administration will warn pregnant women against Tylenol use.
Takeaways:
Stocks pull back as investors await Fed speeches and inflation data
Oracle names co-CEOs as Safra Catz transitions to executive vice chair
Trump orders $100K H-1B visa fee, rattling global tech sector
Pfizer buys obesity drug startup Metsera; Kenvue sinks on Tylenol autism report
Yahoo Finance's flagship show, Morning Brief, is your go-to source for smarter investing and market moves.
Thoughts? Questions? Fan mail? Please email us at yfpodcasts@yahooinc.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices